Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
‘The Price of Business’: Discussing the Future of Working at Home

‘The Price of Business’: Discussing the Future of Working at Home

Apr 13, 2023 | Interviews

‘The Price of Business’: Discussing the Future of Working at Home
On April 13, Alex Brill joined Kevin Price on ‘The Price of Business’ discussing the future of working from home.  
Listen here. Other interviews with Kevin Price can be found here, here and here.

Health Care Workforce Shortages: An Updated Look

Health Care Workforce Shortages: An Updated Look

Feb 21, 2023 | Op-Eds

Last week, the Senate Committee on Health, Education, Labor and Pensions held a hearing titled “Examining Health Care Workforce Shortages: Where Do We Go From Here?”

New MGA Analysis of the Adalimumab Biosimilars Market in the United States

New MGA Analysis of the Adalimumab Biosimilars Market in the United States

Feb 21, 2023 | Analysis, Press Releases

The Biosimilars Council released the following statement in response to the new MGA report authored by Alex Brill and Christy Robinson.

MGA’s Alex Brill on CNBC’s Squawk Box Discussing the Recent Tax Policy Proposal

MGA’s Alex Brill on CNBC’s Squawk Box Discussing the Recent Tax Policy Proposal

Feb 13, 2023 | Interviews

Alex Brill joined CNBC’s Squawk Box to discuss Biden’s billionaire tax policy proposal and why it is not desirable for the U.S. economy. 

Bipartisan Senate Bill Aims to Curb Drug Patent Abuse

Bipartisan Senate Bill Aims to Curb Drug Patent Abuse

Feb 1, 2023 | Interviews

“The patent dance, under current law, places no limits on the number of patents that a branded biologics maker can claim – abusing laws enacted by Congress in 2010 intended to ease biosimilar entry.”

« Older Entries
Next Entries »
  • Analysis (54)
  • Books (3)
  • Commentary (15)
  • Events (22)
  • Interviews (61)
  • News (56)
  • Op-Eds (103)
  • Press Releases (4)
  • Testimony (21)
  • Biosimilars face barriers
    Alex Brill Featured in AxiosJuly 24, 2026
  • Disparate State Impacts and Enormous Cost of a Gas Tax Holiday
    The Disparate State Impacts and Enormous Cost of a Gas Tax HolidayJune 9, 2026
  • Brill discusses tax code and budget challenges
    ‘Facing the Future’: Alex Brill discusses tax code and budget challengesApril 9, 2026
  • Building an Achievable Fiscal Policy
    2026 Portman Center Symposium: Building an Achievable Fiscal PolicyApril 8, 2026
  • Reduced Charitable Giving
    Senator Booker’s Costly Standard Deduction Proposal Would Reduce Charitable GivingApril 7, 2026
  • FDA Continues to Expedite Biosimilar Development
    FDA Continues to Expedite Biosimilar DevelopmentMarch 18, 2026
  • Government’s Drug Negotiation Program
    Diminishing Returns from the Government’s Drug Negotiation ProgramJanuary 29, 2026
  • ACA Tax Credit Extension Matter
    Would Senate Passage of an ACA Tax Credit Extension Matter?January 14, 2026
  • PBMs Pass Through Rebates
    MGA Brief Examines State and Federal PBM MandatesDecember 1, 2025
  • FDA Moves to Facilitate Biosimilar Development
    FDA Moves to Facilitate Biosimilar DevelopmentOctober 30, 2025
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact